Diana Förbs
Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M, Broglie M, Förbs D, Stoeckli S, Jochum W. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma. J Otolaryngol Head Neck Surg 2018; 47:53.
Sep 6, 2018Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Sep 6, 2018J Otolaryngol Head Neck Surg 2018; 47:53
Plath Michaela, Broglie Martina A, Förbs Diana, Stoeckli Sandro J, Jochum Wolfram
Rapid Intracranial Response to Osimertinib in a Patient with Epidermal Growth Factor Receptor T790M-Positive Adenocarcinoma of the Lung
Reichegger H, Jochum W, Förbs D, Hader C, Früh M. Rapid Intracranial Response to Osimertinib in a Patient with Epidermal Growth Factor Receptor T790M-Positive Adenocarcinoma of the Lung. Oncol Res Treat 2016; 39:461-3.
Jun 15, 2016Rapid Intracranial Response to Osimertinib in a Patient with Epidermal Growth Factor Receptor T790M-Positive Adenocarcinoma of the Lung
Jun 15, 2016Oncol Res Treat 2016; 39:461-3
Reichegger Hermann, Jochum Wolfram, Förbs Diana, Hader Claudia, Früh Martin
Brush cytology for the detection of high-risk HPV infection in oropharyngeal squamous cell carcinoma
Broglie Däppen M, Jochum W, Förbs D, Schönegg R, Stöckli S. Brush cytology for the detection of high-risk HPV infection in oropharyngeal squamous cell carcinoma. Cancer Cytopathol 2015; 123:732-8.
Sep 8, 2015Brush cytology for the detection of high-risk HPV infection in oropharyngeal squamous cell carcinoma
Sep 8, 2015Cancer Cytopathol 2015; 123:732-8
Broglie Däppen Martina, Jochum Wolfram, Förbs Diana, Schönegg René, Stöckli Sandro
Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer
Niederer-Wuest S, Stöckli S, ess s, Haile S, Müller J, Oettli R, Clerici T, Bilz S, Brändle M, Förbs D, Jochum W, Broglie Däppen M. Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer. Surgery 2015; 157:119-25.
Jan 1, 2015Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer
Jan 1, 2015Surgery 2015; 157:119-25
Niederer-Wuest Severine, Stöckli Sandro, ess silvia, Haile Sarah, Müller Joachim, Oettli Rene, Clerici Thomas, Bilz Stefan, Brändle Michael, Förbs Diana, Jochum Wolfram, Broglie Däppen Martina